Universität zu Köln

Journal Article

Koschmieder, Steffen, Isfort, Susanne, Heidel, Florian H., Hochhaus, Andreas, Becker, Heiko, Jost, Philipp J., Schafhausen, Philippe, Griesshammer, Martin, Wolleschak, Denise, Haenel, Mathias, Goethert, Joachim R., Teichmann, Lino L., Sockel, Katja, Radsak, Markus P., Reiter, Andreas, Doehner, Konstanze, Balleisen, Sebastian, Jaekel, Nadja, von Bubnoff, Nikolas, Stegelmann, Frank, Gezer, Deniz, Kortmann, Maike, Frank, Julia, Hellmich, Martin and Bruemmendorf, Tim H. (2022). Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN). Blood, 140. S. 1790 - 1794. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Koschmieder, Steffen ORCID: 0000-0002-1011-8171, Isfort, Susanne, Wolf, Dominik, Heidel, Florian H., Hochhaus, Andreas, Schafhausen, Philippe, Griesshammer, Martin, Wolleschak, Denise, Platzbecker, Uwe, Doehner, Konstanze, Jost, Philipp J., Parmentier, Stefani, Schaich, Markus, von Bubnoff, Nikolas, Stegelmann, Frank, Maurer, Angela, Crysandt, Martina, Gezer, Deniz, Kortmann, Maike, Franklin, Jeremy, Frank, Julia, Hellmich, Martin and Bruemmendorf, Tim H. (2023). Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group. Ann. Hematol., 102 (2). S. 349 - 359. NEW YORK: SPRINGER. ISSN 1432-0584

Michel, Christian, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Neubauer, Andreas, Lauseker, Michael, Krause, Stefan W., Kolb, Hans-Jochem, Hossfeld, Dieter Kurt, Nerl, Christoph, Baerlocher, Gabriela M., Heim, Dominik, Bruemmendorf, Tim H., Fabarius, Alice, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Haenel, Mathias, Ho, Anthony, Dengler, Jolanta, Falge, Christiane, Moehle, Robert, Kremers, Stephan, Kneba, Michael, Stegelmann, Frank, Koehne, Claus-Henning, Lindemann, Hans-Walter, Waller, Cornelius F., Spiekermann, Karsten, Berdel, Wolfgang E., Mueller, Lothar, Edinger, Matthias, Mayer, Jiri, Beelen, Dietrich W., Bentz, Martin, Link, Hartmut, Hertenstein, Bernd, Fuchs, Roland, Wernli, Martin, Schlegel, Frank, Schlag, Rudolf, de Wit, Maike, Truemper, Lorenz, Hebart, Holger, Hahn, Markus, Thomalla, Joerg, Scheid, Christof, Schafhausen, Philippe, Verbeek, Walter, Eckart, Michael J., Gassmann, Winfried, Schenk, Michael, Brossart, Peter, Wuendisch, Thomas, Geer, Thomas, Bildat, Stephan, Schaefer, Erhardt, Hasford, Joerg, Hehlmann, Ruediger and Pfirrmann, Markus (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica, 104 (5). S. 955 - 963. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Stegelmann, Frank, Bangerter, Markus, Heidel, Florian H., Griesshammer, Martin, Hebart, Holger, Hochhaus, Andreas, Koschmieder, Steffen, Moehle, Robert, Reiter, Andreas, Scheid, Christof, Kirschbaum, Rebecca, Reim, Regina, Sutter, Ulrike, Vetter, Katrin, Doehner, Hartmut, Schlenk, Richard F. and Doehner, Konstanze (2015). A Phase-Ib/II Study of Ruxolitinib Plus Pomalidomide in Myelofibrosis. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stegelmann, Frank, Hebart, Holger, Bangerter, Markus, Wolleschak, Denise, Griesshammer, Martin, Koschmieder, Steffen, von Bubnoff, Nikolas ORCID: 0000-0001-9593-8947, Moehle, Robert, Kindler, Thomas, Hochhaus, Andreas, Heidel, Florian H., Reiter, Andreas, Scheid, Christof, Kirschbaum, Rebecca, Reim, Regina, Sutter, Ulrike, Vetter, Katrin, Doehner, Hartmut, Schlenk, Richard F. and Doehner, Konstanze (2016). Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020